Merck (MRK) EV to FCF (2009 - 2026)
Merck's (MRK) quarterly EV to FCF came in at 69.23 in Q2 2026, down 7.45% year-over-year from 74.8 in Q2 2025, and down 30.47% quarter-over-quarter from 99.57 in Q1 2026.
Analysis
Merck (MRK) EV to FCF (2009 - 2026) Analysis & Trends
Merck (MRK) has reported EV to FCF for 18 consecutive years, with 69.23 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EV to FCF fell 7.45% year-over-year to 69.23 in Q2 2026; TTM through Jun 2026 was 19.3, a 50.17% increase from a year earlier, with the FY2025 full-year figure at 19.88, up 51.38% from the prior year.
- EV to FCF was 69.23 for Q2 2026 at Merck, down from 99.57 in the prior quarter.
- Over five years, EV to FCF peaked at 782.05 in Q1 2023 and troughed at 362.14 in Q4 2023.
- A 5-year average of 96.61 and a median of 72.21 in 2022 frame the typical range for EV to FCF.
- The widest YoY moves for EV to FCF: up 1387.09% in 2023, down 542.47% in 2023.
- Over 5 years, EV to FCF stood at 81.84 in 2022, then tumbled by 542.47% to 362.14 in 2023, then soared by 126.11% to 94.57 in 2024, then surged by 42.46% to 134.72 in 2025, then plunged by 48.61% to 69.23 in 2026.
- The last three EV to FCF figures came in at 69.23 (Q2 2026), 99.57 (Q1 2026), and 134.72 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.23 |
| Mar 31, 2026 | 99.57 |
| Dec 31, 2025 | 134.72 |
| Sep 30, 2025 | 27.82 |
| Jun 30, 2025 | 74.80 |
| Mar 31, 2025 | 184.49 |
| Dec 31, 2024 | 94.57 |
| Sep 30, 2024 | 32.06 |
| Jun 30, 2024 | 62.43 |
| Mar 31, 2024 | 147.44 |
| Dec 31, 2023 | -362.14 |
| Sep 30, 2023 | 37.00 |
| Jun 30, 2023 | 104.59 |
| Mar 31, 2023 | 782.05 |
| Dec 31, 2022 | 81.84 |
| Sep 30, 2022 | 46.28 |
| Jun 30, 2022 | 69.62 |
| Mar 31, 2022 | 52.59 |
| Dec 31, 2021 | 47.78 |
| Sep 30, 2021 | 49.59 |